Study To Evaluate Minimally Invasive Laser Therapy For Refractory Epilepsy Patients

The FDAhas approved Monteris Medical's Investigational Device Exemptionto evaluate its NeuroBlateSystem in medically refractory epilepsy. With this approval, Monteris will initiate theFeasibility Study onLaser Interstitial ThermalAblation for the Treatment of MedicallyRefractoryEpilepsy (FLARE). This multicenter, open-label prospective study is expected to enroll up to 45 subjects at as many as eight clinical sites in the U.S.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news